This is consistent with the observation that a high expression level of LMP1, glucose transporter 1 (GLUT1), and CD33+MDSCs is frequently reported in NPC sections (Cai et al., 2017). The gene discussed is SLC2A1; the disease is nasopharyngeal carcinoma.